156 related articles for article (PubMed ID: 14561525)
21. Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats.
Morita K; Maeda Y; Masuda M; Kazusaka A; Imaoka S; Funae Y; Fujita S
Biochem Pharmacol; 1998 May; 55(9):1405-11. PubMed ID: 10076532
[TBL] [Abstract][Full Text] [Related]
22. Combined action of phenobarbital and dexamethasone on the activity of rat liver P450 system.
Monostory K; Vereczkey L
Acta Pharm Hung; 1993 Sep; 63(5):296-300. PubMed ID: 8249615
[TBL] [Abstract][Full Text] [Related]
23. Identification of rat cytochrome P450 forms involved in the metabolism of clausenamide enantiomers.
Zhu CJ; Zhang JT
Chirality; 2003 May; 15(5):448-55. PubMed ID: 12692891
[TBL] [Abstract][Full Text] [Related]
24. Predicting the contribution of rat cytochrome P-450 3A1, 3A2 and human cytochrome P-450 3A4, 3A5 to territrem a 4beta-C hydroxylation using the relative activity factor.
Lin YH; Peng FC
J Toxicol Environ Health A; 2008; 71(21):1407-14. PubMed ID: 18800290
[TBL] [Abstract][Full Text] [Related]
25. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
Yu L; Waxman DJ
Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
[TBL] [Abstract][Full Text] [Related]
26. Effects of pretreatment with cytochrome P-450 inducers, especially phenobarbital on triphenyltin metabolism and toxicity in hamsters.
Ohhira S; Matsui H; Watanabe K
Toxicology; 1999 Oct; 137(3):151-9. PubMed ID: 10522495
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450-dependent N-dealkylation of L-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and L-deprenyl.
Valoti M; Fusi F; Frosini M; Pessina F; Tipton KF; Sgaragli GP
Eur J Pharmacol; 2000 Mar; 391(3):199-206. PubMed ID: 10729359
[TBL] [Abstract][Full Text] [Related]
28. Relative contribution of rat CYP isoforms responsible for stereoselective metabolism of carvedilol.
Iwaki M; Niwa T; Nakamura Y; Kawase A; Komura H
J Toxicol Sci; 2018; 43(1):59-63. PubMed ID: 29415952
[TBL] [Abstract][Full Text] [Related]
29. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5.
Picard N; Cresteil T; Prémaud A; Marquet P
Ther Drug Monit; 2004 Dec; 26(6):600-8. PubMed ID: 15570183
[TBL] [Abstract][Full Text] [Related]
31. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of nonylphenol by rat and human microsomes.
Lee PC; Marquardt M; Lech JJ
Toxicol Lett; 1998 Oct; 99(2):117-26. PubMed ID: 9817083
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the induction of rat microsomal cytochrome P450 by tacrine.
Sinz MW; Woolf TF
Biochem Pharmacol; 1997 Aug; 54(3):425-7. PubMed ID: 9278102
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
35. Comparative oxidative metabolism of BDE-47 and BDE-99 by rat hepatic microsomes.
Erratico CA; Moffatt SC; Bandiera SM
Toxicol Sci; 2011 Sep; 123(1):37-47. PubMed ID: 21673328
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
Gardner I; Wakazono H; Bergin P; de Waziers I; Beaune P; Kenna JG; Caldwell J
Carcinogenesis; 1997 Sep; 18(9):1775-83. PubMed ID: 9328175
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers.
Crosbie SJ; Blain PG; Williams FM
Hum Exp Toxicol; 1997 Mar; 16(3):131-7. PubMed ID: 9088965
[TBL] [Abstract][Full Text] [Related]
38. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
39. Induction of liver cytochrome P-450 (CYP) 3A in male and female rats by a steroidal androgen receptor antagonist, zanoterone.
Roberts AE; Ritz MA; Hoekstra S; Descotes G; Hincks JR
J Biochem Toxicol; 1996; 11(3):101-10. PubMed ID: 9029268
[TBL] [Abstract][Full Text] [Related]
40. Metabolic profiling and cytochrome P450 reaction phenotyping of medroxyprogesterone acetate.
Zhang JW; Liu Y; Zhao JY; Wang LM; Ge GB; Gao Y; Li W; Liu HT; Liu HX; Zhang YY; Sun J; Yang L
Drug Metab Dispos; 2008 Nov; 36(11):2292-8. PubMed ID: 18725509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
